TY - JOUR
T1 - The hippocampus in multiple sclerosis
AU - Rocca, Maria A
AU - Barkhof, Frederik
AU - De Luca, John
AU - Frisén, Jonas
AU - Geurts, Jeroen J G
AU - Hulst, Hanneke E
AU - Sastre-Garriga, Jaume
AU - Filippi, Massimo
AU - MAGNIMS study group
AU - Barkhof, Frederik
AU - Ciccarelli, Olga
AU - De Stefano, Nicola
AU - Enzinger, Christian
AU - Filippi, Massimo
AU - Fredriksen, Jette Lautrup
AU - Gasperini, Claudio
AU - Kappos, Ludwig
AU - Palace, Jacqueline
AU - Rocca, Maria A
AU - Rovira, Alex
AU - Sastre-Garriga, Jaume
AU - Vrenken, Hugo
AU - Yousry, Tarek A
N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Some of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathological studies have shown extensive demyelination, neuronal damage, and synaptic abnormalities in the hippocampus of patients with multiple sclerosis, and improvements in MRI technology have provided novel ways to assess hippocampal involvement in vivo. It is now accepted that clinical manifestations related to the hippocampus are due not only to focal hippocampal damage, but also to disconnection of the hippocampus from several brain networks. Evidence suggests anatomical and functional subspecialisation of the different hippocampal subfields, resulting in variability between regions in the extent to which damage and repair occur. The hippocampus also has important roles in plasticity and neurogenesis, both of which potentially contribute to functional preservation and restoration. These findings underline the importance of evaluation of the hippocampus not only to improve understanding of the clinical manifestations of multiple sclerosis, but also as a potential future target for treatment.
AB - Some of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathological studies have shown extensive demyelination, neuronal damage, and synaptic abnormalities in the hippocampus of patients with multiple sclerosis, and improvements in MRI technology have provided novel ways to assess hippocampal involvement in vivo. It is now accepted that clinical manifestations related to the hippocampus are due not only to focal hippocampal damage, but also to disconnection of the hippocampus from several brain networks. Evidence suggests anatomical and functional subspecialisation of the different hippocampal subfields, resulting in variability between regions in the extent to which damage and repair occur. The hippocampus also has important roles in plasticity and neurogenesis, both of which potentially contribute to functional preservation and restoration. These findings underline the importance of evaluation of the hippocampus not only to improve understanding of the clinical manifestations of multiple sclerosis, but also as a potential future target for treatment.
KW - Cognitive Dysfunction/diagnostic imaging
KW - Hippocampus/diagnostic imaging
KW - Humans
KW - Multiple Sclerosis/complications
U2 - 10.1016/S1474-4422(18)30309-0
DO - 10.1016/S1474-4422(18)30309-0
M3 - Comment/debate
C2 - 30264730
SN - 1474-4422
VL - 17
SP - 918
EP - 926
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 10
ER -